Fenofibrate-Induced Hyperhomocysteinaemia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference73 articles.
1. Triglyceride Concentration and Ischemic Heart Disease
2. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.
3. The role of fibric acids in atherosclerosis
4. Increasing high-density lipoprotein cholesterol: an update on fenofibrate
5. Effectiveness and Tolerability of 12-Week Treatment with Micronised Fenofibrate 200mg in a Drug-Monitoring Programme Involving 9884 Patients with Dyslipidaemia
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The impact of vitamin D status on cardiometabolic effects of fenofibrate in women with atherogenic dyslipidemia;Clinical and Experimental Pharmacology and Physiology;2020-11-15
2. Macroprolactinaemia modulates cardiometabolic effects of fenofibrate in men with atherogenic dyslipidaemia: A pilot study;Journal of Clinical Pharmacy and Therapeutics;2019-08-24
3. Molecular targets of fenofibrate in the cardiovascular-renal axis: A unifying perspective of its pleiotropic benefits;Pharmacological Research;2019-06
4. Different effects of fenofibrate on cardiometabolic risk factors in young women with and without hyperprolactinemia;Pharmacological Reports;2019-02
5. The effect of fenofibrate on cardiometabolic risk factors in bromocriptine-treated women with mixed dyslipidemia: A pilot study;Pharmacological Reports;2016-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3